share_log

Chardan Capital Maintains Buy on Notable Labs, Lowers Price Target to $7

Chardan Capital Maintains Buy on Notable Labs, Lowers Price Target to $7

Chardan Capital维持对著名实验室的买入,将目标股价下调至7美元
Moomoo 24/7 ·  04/15 07:43

Chardan Capital analyst Keay Nakae maintains Notable Labs (NASDAQ:NTBL) with a Buy and lowers the price target from $9 to $7.

查丹资本分析师Keay Nakae维持Notality Labs(纳斯达克股票代码:NTBL)的买入并将目标股价从9美元下调至7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发